BIOMEDICAL

AbSci develops game-changing 12-week cell line optimization workflow and adds two new members to its executive team

Read now on PRNewswire.com • April 5, 2019

Sanofi enters agreement to use E.Coli for expression optimization

Read now on Outsourcing-Pharma.com • January 15, 2019

Enterobacterias Gram negativas Proteobacteria, bacteria such as salmonella, escherichia coli, yersinia pestis, klebsiella. 3D illustration.

Sanofi turns to high titer E. Coli platform in AbSci deal

Read now on BioProcessIntl@.com • January 14, 2019

e-coli-wikimedia

AbSci, Sanofi in manufacturing partnership

Read now on BioPharmInternational.com • January 11, 2019

AbSci teams up with global pharmaceutical company

Read now on Columbian.com • January 10, 2019

Biomanufacturing technologies maker AbSci collaborates with Sanofi

Read now on HealthcareOpportunity.org • January 10, 2019

biomanufacturing-technologies-maker-absci-collaborates-with-sanofi-620x315

AbSci establishes new collaboration with Sanofi

Read now on PRNewswire.com • January 9, 2019